Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.6M | 897 | 75.2% |
| Travel and Lodging | $440,814 | 952 | 12.6% |
| Consulting Fee | $214,266 | 84 | 6.1% |
| Honoraria | $107,505 | 30 | 3.1% |
| Food and Beverage | $79,351 | 1,178 | 2.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $21,260 | 6 | 0.6% |
| Education | $4,620 | 24 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $608,433 | 630 | $0 (2024) |
| ABBVIE INC. | $564,956 | 490 | $0 (2024) |
| Celgene Corporation | $434,912 | 292 | $0 (2019) |
| Amgen Inc. | $269,401 | 207 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $186,642 | 202 | $0 (2024) |
| UCB, Inc. | $183,153 | 152 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $176,391 | 192 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $159,790 | 144 | $0 (2024) |
| PFIZER INC. | $154,961 | 109 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $147,278 | 134 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $368,228 | 366 | ABBVIE INC. ($75,521) |
| 2023 | $554,822 | 515 | Lilly USA, LLC ($103,922) |
| 2022 | $511,908 | 438 | Lilly USA, LLC ($93,743) |
| 2021 | $313,129 | 245 | Lilly USA, LLC ($68,232) |
| 2020 | $223,063 | 188 | AbbVie Inc. ($61,249) |
| 2019 | $547,219 | 484 | Celgene Corporation ($117,976) |
| 2018 | $521,977 | 522 | Celgene Corporation ($116,795) |
| 2017 | $458,487 | 413 | Celgene Corporation ($200,140) |
All Payment Transactions
3,171 individual payment records from CMS Open Payments — Page 1 of 127
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Consulting Fee | Cash or cash equivalent | $1,810.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,805.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $584.80 | General |
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Travel and Lodging | Cash or cash equivalent | $758.28 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $117.96 | General |
| Category: Immunology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $101.68 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $1,285.81 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $753.65 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $669.18 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $539.28 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $506.91 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $444.05 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $438.16 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $393.95 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $233.08 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $209.48 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $188.00 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $155.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 23 | 33 | $16,649 | $2,014 |
| 2020 | 2 | 26 | 34 | $16,306 | $1,528 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 20 | $11,540 | $1,579 | 13.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $5,109 | $435.31 | 8.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 16 | $9,232 | $824.71 | 8.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 18 | $7,074 | $702.83 | 9.9% |
About Dr. John Koo, MD
Dr. John Koo, MD is a Dermatology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245289594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Koo, MD has received a total of $3.5M in payments from pharmaceutical and medical device companies, with $368,228 received in 2024. These payments were reported across 3,171 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.6M).
As a Medicare-enrolled provider, Koo has provided services to 49 Medicare beneficiaries, totaling 67 services with total Medicare billing of $3,542. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Psychiatry
- Location San Francisco, CA
- Active Since 05/06/2006
- Last Updated 09/11/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1245289594
Products in Payments
- Otezla (Drug) $692,303
- TALTZ (Drug) $429,385
- DUPIXENT (Biological) $263,499
- SKYRIZI (Biological) $192,926
- Humira (Biological) $187,147
- COSENTYX (Biological) $175,916
- TREMFYA (Drug) $159,985
- CIBINQO (Drug) $148,295
- RINVOQ (Biological) $122,160
- Cimzia (Drug) $97,938
- OLUMIANT (Drug) $90,478
- Sotyktu (Drug) $76,808
- ILUMYA (Biological) $75,812
- ADBRY (Biological) $75,084
- Tremfya (Drug) $65,262
- DUPIXENT (Drug) $57,145
- Skyrizi (Biological) $52,239
- SILIQ (Drug) $45,348
- Ilumya (Biological) $42,304
- VTAMA (Drug) $34,642
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Francisco
Dr. Mary Spellman, M.d, M.D
Dermatology — Payments: $756,356
Tina Bhutani-Jacques, Md, MD
Dermatology — Payments: $472,684
Dr. Michael Rosenblum, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $312,856
Dr. Howard Maibach, M.d, M.D
Dermatology — Payments: $272,402
Dr. Sarina Elmariah, M.d, Ph.d, M.D, PH.D
Dermatology — Payments: $231,513
Dr. Timothy Berger, Md, MD
Dermatology — Payments: $227,824